SKT and SK Biopharm use AI to accelerate early-stage cancer drug discovery

Wait 5 sec.

(Telecompaper) SK Telecom (SKT) and SK Biopharm said they have identified two early-stage drug candidates for a targeted treatment for hard-to-treat cancers through a joint AI-based drug discovery project...